Study gauges emotional toll of direct-to-consumer genetic testing
Monday, October 3, 2011 - 22:30
in Health & Medicine
Among the latest health care trends seeking to advance "individualized medicine" are private companies marketing genetic testing directly to patients. The mail-in kits, with price tags as high as $2,500, use a saliva specimen to identify small variations in the human genome associated with heightened risk for diseases such as diabetes and prostate cancer.